Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...

A lawsuit filed by a national pharmacy chain and its subsidiaries in the Little Rock federal court on Thursday seeks to ...

A lawsuit was filed in Little Rock federal court on Thursday to overturn an Arkansas law preventing pharmacy benefit managers ...

Choosing dividend stocks is not only about looking at the yield but also ensuring that the company pays regular dividends, ...

The hedge fund billionaire’s take on how to fix America’s fiscal woes is getting a warm reception in Washington, even as he ...

With 14 drugs posting double-digit sales growth in the most recent quarter, a promising obesity drug in late-stage trials, ...

Trichy: Three people including a minor were arrested on Tuesday for robbing a pharma company manager in Trichy last week. S ...

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...

ProteinQure Inc., a biotechnology company pioneering computational peptide therapeutics, announced today the close of an $11 million Series A financing round. The proceeds will support the initiation ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

Daniel S. Reshef currently works at Fragrant Prosperity Holdings Ltd., as Non-Executive Director from 2021, Alterola Biotech, Inc., as Independent Executive Director, and Two Hands Corp., as Director ...